Hydrosoluble extracts of mycobacteria
US4001395A · kind A · utility
Assignee
Inventors
Key dates
| Filing date | Sep 4, 1975 |
| Grant date | Jan 4, 1977 |
| Priority date | — |
| Expiry date | Sep 4, 1995 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/55594
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Hydrosoluble extracts of mycobacteria suitable as immunological adjuvants are prepared. These extracts have a molecular weight between 3,500 and 30,000 and adjuvant, non-arthrogenic properties. The delipidated bacterial residues of mycobacteria are subjected to a mild extraction, then the so-obtained substance is isolated and purified by physicochemical methods, or the delipidated bacterial residues of mycobacteria are treated by means of pyridine optionally in the presence of acetic anhydride, then the obtained products are treated with ethanol or water, and the hydrosoluble substances are isolated and purified by physicochemical methods.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.